Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barrow

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 2, 2018
Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screeningRoland W Bürli, Huijun Wei, Glen Ernst, et al.
Psychopharmacology|June 1, 2020
Novel, non-nitrocatechol catechol-O-methyltransferase inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibilitySpencer Byers, Ingrid P Buchler, Michael DePasquale, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Ribosomal RNA transcription governs splicing through ribosomal protein RPL22Wenjun Fan, Hester Liu, Gregory C Stachelek, et al.
Cell Chemical Biology|June 24, 2025
Ribosomal RNA transcription regulates splicing through ribosomal protein RPL22Wenjun Fan, Hester Liu, Gregory C Stachelek, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Design and synthesis of potent and selective macrocyclic thrombin inhibitorsPhilippe G Nantermet, James C Barrow, Christina L Newton, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-onesP G Nantermet, J C Barrow, H G Selnick, et al.
Molecular Psychiatry|February 10, 2016
KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophreniaGregory V Carr, Jingshan Chen, Feng Yang, et al.
Neuropharmacology|November 30, 2010
T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of ratsJason M Uslaner, Sean M Smith, Sarah L Huszar, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M(1) positive allosteric modulatorsFeng V Yang, William D Shipe, Jaime L Bunda, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Bioorganic & Medicinal Chemistry Letters|September 2, 2018
Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screeningRoland W Bürli, Huijun Wei, Glen Ernst, et al.
Psychopharmacology|June 1, 2020
Novel, non-nitrocatechol catechol-O-methyltransferase inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibilitySpencer Byers, Ingrid P Buchler, Michael DePasquale, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Ribosomal RNA transcription governs splicing through ribosomal protein RPL22Wenjun Fan, Hester Liu, Gregory C Stachelek, et al.
Cell Chemical Biology|June 24, 2025
Ribosomal RNA transcription regulates splicing through ribosomal protein RPL22Wenjun Fan, Hester Liu, Gregory C Stachelek, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Design and synthesis of potent and selective macrocyclic thrombin inhibitorsPhilippe G Nantermet, James C Barrow, Christina L Newton, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-onesP G Nantermet, J C Barrow, H G Selnick, et al.
Molecular Psychiatry|February 10, 2016
KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophreniaGregory V Carr, Jingshan Chen, Feng Yang, et al.
Neuropharmacology|November 30, 2010
T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of ratsJason M Uslaner, Sean M Smith, Sarah L Huszar, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M(1) positive allosteric modulatorsFeng V Yang, William D Shipe, Jaime L Bunda, et al.
Pageof 14